Literature DB >> 33451062

In Vitro and In Vivo Effect of Peptides Derived from 14-3-3 Paracoccidioides spp. Protein.

Liliana Scorzoni1, Ana Carolina Alves de Paula E Silva1, Haroldo Cesar de Oliveira1, Claudia Tavares Dos Santos1, Junya de Lacorte Singulani1, Patricia Akemi Assato1, Caroline Maria Marcos1, Lariane Teodoro Oliveira1, Nathália Ferreira Fregonezi1, Diego Conrado Pereira Rossi2, Leandro Buffoni Roque da Silva2, Carlos Pelleschi Taborda2, Ana Marisa Fusco-Almeida1, Maria José Soares Mendes-Giannini1.   

Abstract

BACKGROUND: Paracoccidioidomycosis (PCM) is a chronic disease that causes sequelae and requires prolonged treatment; therefore, new therapeutic approaches are necessary. In view of this, three peptides from Paracoccidioides brasiliensis 14-3-3 protein were selected based on its immunogenicity and therapeutic potential.
METHODS: The in vitro antifungal activity and cytotoxicity of the 14-3-3 peptides were evaluated. The influence of the peptides in immunological and survival aspects was evaluated in vivo, using Galleria mellonella and the expression of antimicrobial peptide genes in Caenorhabditis elegans.
RESULTS: None of the peptides were toxic to HaCaT (skin keratinocyte), MRC-5 (lung fibroblast), and A549 (pneumocyte) cell lines, and only P1 exhibited antifungal activity against Paracoccidioides spp. The peptides could induce an immune response in G. mellonella. Moreover, the peptides caused a delay in the death of Paracoccidioides spp. infected larvae. Regarding C. elegans, the three peptides were able to increase the expression of the antimicrobial peptides. These peptides had essential effects on different aspects of Paracoccidioides spp. infection showing potential for a therapeutic vaccine. Future studies using mammalian methods are necessary to validate our findings.

Entities:  

Keywords:  14-3-3 protein; Caenorhabditis elegans; Galleria mellonella; Paracoccidioides spp.; paracoccidioidomycosis; vaccine

Year:  2021        PMID: 33451062      PMCID: PMC7828505          DOI: 10.3390/jof7010052

Source DB:  PubMed          Journal:  J Fungi (Basel)        ISSN: 2309-608X


  74 in total

Review 1.  Diagnosis, management and prevention of Candida auris in hospitals: position statement of the Australasian Society for Infectious Diseases.

Authors:  Chong W Ong; Sharon C-A Chen; Julia E Clark; Catriona L Halliday; Sarah E Kidd; Deborah J Marriott; Caroline L Marshall; Arthur J Morris; C Orla Morrissey; Rita Roy; Monica A Slavin; Andrew J Stewardson; Leon J Worth; Christopher H Heath
Journal:  Intern Med J       Date:  2019-10       Impact factor: 2.048

2.  Inhibitory effects of the essential oils α-longipinene and linalool on biofilm formation and hyphal growth of Candida albicans.

Authors:  Ranjith Kumar Manoharan; Jin-Hyung Lee; Yong-Guy Kim; Soon-Il Kim; Jintae Lee
Journal:  Biofouling       Date:  2017-02-03       Impact factor: 3.209

3.  Red death in Caenorhabditis elegans caused by Pseudomonas aeruginosa PAO1.

Authors:  Alexander Zaborin; Kathleen Romanowski; Svetlana Gerdes; Christopher Holbrook; Francois Lepine; Jason Long; Valeriy Poroyko; Stephen P Diggle; Andreas Wilke; Karima Righetti; Irina Morozova; Trissa Babrowski; Donald C Liu; Olga Zaborina; John C Alverdy
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-06       Impact factor: 11.205

Review 4.  Immunity of the greater wax moth Galleria mellonella.

Authors:  Iwona Wojda
Journal:  Insect Sci       Date:  2016-05-25       Impact factor: 3.262

5.  Estimation of Direct Healthcare Costs of Fungal Diseases in the United States.

Authors:  Kaitlin Benedict; Brendan R Jackson; Tom Chiller; Karlyn D Beer
Journal:  Clin Infect Dis       Date:  2019-05-17       Impact factor: 9.079

6.  Candida albicans infection of Caenorhabditis elegans induces antifungal immune defenses.

Authors:  Read Pukkila-Worley; Frederick M Ausubel; Eleftherios Mylonakis
Journal:  PLoS Pathog       Date:  2011-06-23       Impact factor: 6.823

7.  Genome Diversity, Recombination, and Virulence across the Major Lineages of Paracoccidioides.

Authors:  José F Muñoz; Rhys A Farrer; Christopher A Desjardins; Juan E Gallo; Sean Sykes; Sharadha Sakthikumar; Elizabeth Misas; Emily A Whiston; Eduardo Bagagli; Celia M A Soares; Marcus de M Teixeira; John W Taylor; Oliver K Clay; Juan G McEwen; Christina A Cuomo
Journal:  mSphere       Date:  2016-09-28       Impact factor: 4.389

8.  Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis.

Authors:  Leandro B R Silva; Lucas S Dias; Glauce M G Rittner; Julián E Muñoz; Ana C O Souza; Joshua D Nosanchuk; Luiz R Travassos; Carlos P Taborda
Journal:  Front Microbiol       Date:  2017-06-14       Impact factor: 5.640

9.  From moths to caterpillars: Ideal conditions for Galleria mellonella rearing for in vivo microbiological studies.

Authors:  Adeline L Jorjão; Luciane D Oliveira; Liliana Scorzoni; Lívia Mara A Figueiredo-Godoi; Marcia Cristina A Prata; Antonio Olavo C Jorge; Juliana C Junqueira
Journal:  Virulence       Date:  2018-01-01       Impact factor: 5.882

10.  Specificity and complexity of the Caenorhabditis elegans innate immune response.

Authors:  Scott Alper; Sandra J McBride; Brad Lackford; Jonathan H Freedman; David A Schwartz
Journal:  Mol Cell Biol       Date:  2007-05-25       Impact factor: 4.272

View more
  1 in total

1.  Prospecting Biomarkers for Diagnostic and Therapeutic Approaches in Pythiosis.

Authors:  Jéssica Luana Chechi; Tiwa Rotchanapreeda; Giselle Souza da Paz; Ana Carolina Prado; Alana Lucena Oliveira; José Cavalcante Souza Vieira; Marília Afonso Rabelo Buzalaf; Anderson Messias Rodrigues; Lucilene Delazari Dos Santos; Theerapong Krajaejun; Sandra de Moraes Gimenes Bosco
Journal:  J Fungi (Basel)       Date:  2021-05-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.